. A role for Hh signaling has been reported in metastasis (6) (7) (8) .
The Hh family of secreted proteinsSonic (Shh), Indian (Ihh), and Desert Hedgehog (Dhh) -exerts its functions by binding to the 12-transmembrane (12-TM) receptor Patched1 (Ptc1) and, in a restricted cell population, Patched2 (Ptc2). Binding of Hh proteins to Ptc1 results in de-repression of the 7-TM protein Smoothened (SMO). Ptc1 is thought to inhibit the activity of SMO by preventing its accumulation in the primary cilium, a single immotile flagellar-like structure derived from the centrosome present in most cells during interphase and after cell cycle exit (9, 10) . Translocation of SMO to the primary cilium by lateral diffusion from the plasma membrane in response to Hh is presumed to cause a conformational change resulting in stimulation of transcription by the Gli family of transcription factors (Gli1, Gli2, and Gli3) (11) (12) (13) .
We recently demonstrated that SMO has the capacity to signal through heterotrimeric G proteins (14) . We showed, using [ 35 S]GTPγS binding, that SMO can activate all members of the G i family of G proteins and was highly selective in this regard. This property is required, in NIH 3T3 cells, for activation of Gli-dependent transcription by Shh, as it is blocked by a Bordetella pertussis toxin (PTX) (14) , which uncouples most members of the G i family from 7-TM receptors. Whether G i is required in all cell types for activation of Gli transcription factors, however, is unlikely given the paucity of data regarding PTX in this context. Expression of PTX in the developing neural tube failed to perturb the classical morphogenetic function of Shh (15) , for example, however in this instance as neural progenitors express G z , a PTXresistant form of G i , it is conceivable that G z compensates for the inhibition of other G i family isoforms.
While the best-characterized cellular responses to Hh involve Gli-dependent transcription and occur over the course of hours if not days, many cell types respond to Hh in a seemingly Gli-independent fashion (16) . Examples of the so called "non canonical" Hh signaling are fibroblast migration, endothelial cell tubulogenesis, and axon growth cone repulsion, all of which are underlined by cytoskeletal changes (17) (18) (19) . Fibroblasts deficient in Gli2 and Gli3 migrate in response to Shh indistinguishably from wild type counterparts (17) . While these cells still express very low levels of Gli1, the absence of an effect of Gli2/Gli3 deficiency and the time-frame of the response suggest that Shh-induced cell migration is independent of Gli transcriptional activity.
We previously demonstrated in human endothelial cells that Hh isoforms are capable of stimulating the monomeric G protein RhoA in a G i -dependent manner (18) . In the present study, we sought to investigate the mechanistic basis underlying Shh-induced fibroblast migration, in particular to establish the role of coupling of SMO to G i in this paradigm. Our results reveal a strict requirement for G i and phosphoinositide 3-kinase (PI3K) in Shh-induced fibroblast migration, which is mediated by the rapid stimulation of Rac1 and RhoA small GTPases. We show as well that activation of the monomeric GTPases by SMO does not require Gli transcriptional activity nor any other signal encoded by the cytoplasmic C-tail of SMO. These results suggest that SMO initiates canonical and non-canonical responses to Hh stimulation via separate domains, and that G i proteins play a central role in non-canonical signaling by linking Hh signaling to small Rho GTPases.
Experimental procedures
Reagents-KAAD-cyclopamine, purmorphamine, and LY294002 were from EMD Biosciences (Madison, WI). Pertussis toxin was purchased from Sigma-Aldrich (St. Louis, MO). Anti-RhoA (67B9) rabbit mAb antibody was obtained from Cell Signaling Technology Inc, (Danvers, MA), anti-Rac mouse clone 23A8 Ab from Millipore (Billerica, MA), and anti-SMO E5 mAb was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary anti-rabbit-HRP and antimouse-HRP antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA) and rhodaminephalloidin was purchased from Molecular Probes (Eugene, OR). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were from Mediatech Inc. (Waltham, MA), and newborn calf serum (NCS) was from Invitrogen (Carlsbad, CA). Plasmids and adenoviral vectors-Mouse SMO-M2 (obtained from P. Beachy, Stanford University) was subcloned into the pcDNA3.1+ vector. A C-terminal deletion, SMO-M2 (1-551), was created by PCR amplification and re-cloning. SMO-M2-CLD (W549A; R550A) was constructed by site-directed mutagenesis of full length SMO-M2 plasmid using the QuikChange kit (Agilent Technologies, Santa Clara, CA). The vector series pAX142, pAX142-RhoN19 and pAX142-RacN17 were a generous gift of Dr. Andrew Aplin (Thomas Jefferson University). All other plasmids were previously described (14) . GFP AdV particles were a gift of Dr. Wally Koch (Thomas Jefferson University). Gli3R-GFP AdV was generated by homologous recombination of pShuttle-Gli3R-GFP (a generous gift of Dr. Bradley Yoder, University of Alabama) with the AdV backbone following the Adeno-X kit's directions (Clontech, Mountain View, CA). AdV particles were amplified in AD-293 cells, and the titer was determined using the AdEasy Viral Titer kit (Agilent Technologies, Santa Clara, CA). Synthesis and purification of Hedgehog proteinsRecombinant Shh ligand was synthesized and purified as previously described (20) . Briefly, Shh was synthesized as CBP-fusion proteins in E. coli, purified using a calmodulin-affinity column with elution achieved by calcium. The purified fusion protein (inactive) was then cleaved at a single enterokinase site to release the intact (active) protein, which was then separated from the CBP peptide and cleaned from endotoxin contamination using Detoxi-Gel purification columns (Pierce, Rockford, IL). The specific activity was estimated by ability to induce a Gli-luciferase reporter in Light II fibroblasts in comparison to 5 µM purmorphamine (20) . (21, 22) . Briefly, NIH 3T3, Ptc1 +/-, and Ptc1 -/-fibroblasts were plated on 5-cm culture dishes and, prior to attaining confluence, were starved 16 h. The cells were then incubated with Shh (5 minutes for Rac1 and 15 minutes for RhoA) and lysed in 25 mM HEPES pH 7.5, 150 mM NaCl, 1% NP-40, 10 mM MgCl 2 , 1 mM EDTA and 2% glycerol, and the lysate was clarified by centrifugation at 12,000 × g for 10 min. A portion of the supernatant aliquot was retained for measurement of total Rac1 and RhoA, while the remaining supernatant was incubated for 1 h at 4 °C with PBD-GST or RBD-GST bound to GSH-sepharose 4B beads (GE Healthcare, Piscataway, NJ). Beads were washed 3 times, and bound proteins were eluted with Laemmli buffer, separated in 12% SDS polyacrylamide gels (Mini Protean II System, BioRad, Hertz, UK), and transferred onto nitrocellulose membranes. For RhoA detection, membranes were blocked in 5% bovine serum albumin-TBST (20 mM Tris, 150 mM NaCl, pH 7.5 containing 0.1% Tween-20), washed 3 times with TBST and incubated with anti-RhoA (67B9) rabbit mAb antibody (1:1,000) overnight at 4°C. For Rac1 detection, membranes were blocked in PBS containing 3% nonfat dry milk at room temperature for 1h, followed by 5 washes with mQ water and overnight incubation with anti-Rac1 23A8 mAb (1:1,000) at 4°C. After 3 washes with TBST for RhoA and five washes with mQ water for Rac1, the membranes were incubated with HRP-conjugated secondary antibodies at room temperature for 2 hours. After extensive washing, the membranes were developed using the Western Lightning-ECL reagent (Perkin Elmer, Shelton, CT). Band intensities were quantified using the free ImageJ software (NIH). Densitometric values were first normalized to total RhoA or total Rac1 levels and then expressed as fold differences over the control treatment. When inhibitors were used, they were added 45 min before Shh or purmorphamine treatment except for PTX, which was added overnight prior to treatment. Semi-quantitative RT-PCR-Total RNA was isolated from cells using the RNeasy kit (QIAGEN, Valencia, CA) as directed. cDNA was synthesized from 2 µg RNA using the SuperScriptIII System (Invitrogen, Carlsbad, CA) with hexa-random primers following the protocol provided by the manufacturer. One µl cDNA were used for PCR using the following sequencespecific primers: Gli1-F, 5'-GGA CCTGCA GAC GGT TAT CC; Gli1-R, 5'-AGC CTC CTG GAG ATG TGC AT; Ptc1-F, 5'-CGA TGG AGT CCT TGCCTA CAA; Ptc1-R, 5'-CCA CCA GAC GCT GTT TAG TCA; S15-F, 5'-TTC CGC AAGTTC ACC TAC C; and S15-R, 5'-CGG GCC GGC CAT GCTTTA CG. Wound healing assays-. The cells were seeded in 12-well plates (pre-coated with 2% gelatin) and cultured in complete media until confluent. At that point, media were replaced by DMEM containing 0.5% FBS for 24 h. Inhibitors or vehicles were added during the last 12 hours (PTX, 100 ng/ml) or 45 minutes (15 µM LY294002 or 0.5 µM KAAD-CP) before t=0. At t=0, cells were washed once with PBS, and a scratch was made with an Eppendorf P20 pipette tip. PBS was replaced immediately with DMEM containing 0.5% FBS without or with purified Shh (2.5 µg/ml) or purmorphamine (5 µM) with or without inhibitors. Pictures of four zones along the scratch were taken at t=0 h and t=8 h using a Nikon Eclipse TS100 inverted microscope. For each sample, five distance measurements (in µm) were taken at evenly spaced points along the scratch at t=0 h and t=8 h, and cell migration was expressed as the (mean t=8 -mean t=0) for each sample. Results were expressed as µm in 8 h or percentage relative to the control group.
Statistics.-Experiments comparing two groups were analyzed by paired Student's t-test. Those experiments involving comparison of three or more groups were analyzed by One way ANOVA followed by Tukey's multiple comparisons test using GraphPad Prism 5.0.
RESULTS

Sonic Hedgehog promotes fibroblast migration in a Smoothened-dependent manner.
In order to determine if the coupling of SMO to one or more members of the G i family has a role in fibroblast migration, we wanted first to establish whether cell migration induced by Shh is strictly dependent on SMO, as other routes of Shh signaling exist (16, 18) . To this end we compared the effect of Shh to that of purmorphamine, a direct SMO agonist, on migration. We used two cell lines to confirm the results, immortalized Ptc1 +/-MEFs and NIH 3T3 fibroblasts. The first, which were used as a matter of convenience, behave and respond like wild-type MEFs to Shh (23, and see below). Both Shh and purmorphamine stimulated migration of the cells 2-2.5 fold as determined by scratch-wound healing assays (Figs. 1A and B and 1S, black bars). The response to the two agonists is comparable to other pro-migratory stimuli for fibroblasts, for example PDGF-BB (24) . Pretreatment of cells with an inverse agonist specific for SMO, KAAD-cyclopamine, which prevents activation of Gli-dependent transcription as well as stimulation of G i proteins by SMO (14) , completely blocked cell migration in response to both agonists ( Fig. 1A and B and 1S, white bars). The basal rate of migration was similar in KAADcyclopamine-and vehicle (DMSO)-treated cells. These data, obtained with immortalized fibroblasts, demonstrate that Shhand purmorphamine-elicited migration requires SMO. We extended the studies as well to primary MEFs. Complete Ptc1 deficiency results in de-repressed constitutive activation of SMO and embryonic lethality between 9.5-10 dpc (25 +/-MEFs and insensitive to purmorphamine and KAAD-cyclopamine modulation. Altogether, the data confirm that Shh promotes fibroblast migration and establish that SMO is necessary and sufficient for this process.
Activation of PI3K/Akt and G i is essential for SMO-induced migration. Shh stimulates PI3K and Akt activities in fibroblasts and many other cells (26, 27) . As shown in Fig. 2A , direct stimulation of SMO with purmorphamine increased Akt phosphorylation at Ser473 in Ptc1 +/-MEFs in a manner sensitive to KAADcyclopamine. Akt is often downstream of G i and PI3K. To determine whether SMO promotes migration of fibroblasts via stimulation of G i and/or PI3K, we pre-treated Ptc1 +/-MEFs with PTX or with LY294002, respectively. Both inhibitors completely blocked purmorphaminestimulated migration (Fig. 2B) .
We evaluated Ptc1 -/-and SMO -/-MEFs as well. In Ptc1 -/-MEFs, basal phosphorylation level of PDK-1 and Akt in the absence of serum was sensitive to inhibition by KAAD-cyclopamine and PTX (Fig. 2C) . These data suggest that unconstrained activation of SMO in the absence of Ptc1 is able to maintain PI3K/Akt activation in a G i -dependent manner. In SMO -/-MEFs, PDK-1 and Akt phosphorylation was not affected by KAAD-cyclopamine or PTX (Fig. 2D) , as was the case in Ptc1 +/-cells in the absence of Hh stimulation (Fig. 2E) . Basal migration of Ptc1 -/-MEFs was reduced by PTX and LY294002 (Fig.  2F , gray bars), comparable to the inhibitory effect of KAAD-cyclopamine. In contrast, SMO -/-MEFs migrated at a similar rate in the presence of vehicle, PTX, or LY294002 (Fig. 2F, black bars) . These data confirm that the G i /PI3K/Akt axis operates downstream of SMO to promote fibroblast migration.
Sonic Hedgehog stimulates the small GTPases Rac1 and RhoA. Cell migration requires the coordinated activation of Rac and Rho, members of the Rho family of small GTPases. Shh might therefore regulate actin cytoskeleton dynamics through members of this family. To determine whether this is the case, we performed pulldown assays in NIH 3T3 cells stimulated with Shh. As shown in Fig. 3A and B, Shh induced a by guest on January 9, 2018 http://www.jbc.org/ Downloaded from biphasic activation of Rac1, with an early pick at 5 min and a later increase at 15 min. Shh also stimulated RhoA with a maximal effect between 5 and 10 min, to decline afterwards ( Fig. 3C and D) . Moreover, migration of NIH 3T3 cells was strictly dependent on coordinated activation of Rac and Rho GTPases, since expression of dominant negative RhoN19 or dominant negative RacN17 abrogated cell motility (Fig. 3E and F) . Exposure of Ptc1 +/-MEFs to Shh also led to strong activation of both RhoA and Rac1 (Fig. 4) , suggesting that this was not an exclusive feature of NIH 3T3 fibroblasts. Next, we reasoned that if Shh stimulates Rac1 and RhoA activity in a SMOdependent manner, the high SMO activity in Ptc1 -/-MEFs should be reflected in a high constitutive activition of those small GTPases. Indeed, Ptc1 -/-MEFs showed an already high level of GTP-RhoA and GTP-Rac1 (Fig. 4) , comparable or higher than the Ptc1 +/-cells stimulated with Shh. This increase in RhoA and Rac1 activity in Ptc1 -/-MEFs is dependent on SMO, since it was completely reduced to normal levels by pre-treatment of the cells with KAAD-cyclopamine.
Since migration induced by Shh requires G i and PI3K, we examined whether activation of Rac1 and RhoA was mediated by the same pathway. Pre-treatment of NIH 3T3 cells with PTX and LY294002 blocked RhoA activation to a similar extent that KAAD-cyclopamine ( Fig. 5A and C). Shh stimulated Rac1-GTP loading was equally sensitive to LY294002, PTX, and KAADcyclopamine ( Fig. 5B and D) .
Lastly, we evaluated if activation of RhoA and Rac1 by G i and PI3K are independent events or if the activation of Rac is necessary for that of Rho. For this purpose, Ptc1 +/-MEFs were transduced with a control GFP AdV or a dominant negative mutant RacN17 AdV at MOI = 150 and, after 24 h, the cells were placed in serum-free medium. Addition of Shh elicited a robust activation of RhoA in GFP AdV-infected cells but a ~ 50% lower activation in RacN17-expressing cells (Fig. 6A ), which correlates with an approximate 50% viral infection efficiency. In contrast, introduction of dominant negative Rho mutant (RhoN19) in Ptc1 +/-MEFs did not perturb Rac1 activation when compared to GFPexpressing cells (Fig. 6B) . These results suggest that the Shh-mediated activation of RhoA is at least partly dependent on Rac activity.
Altogether, these findings reveal a novel mechanism linking SMO to small GTPases of the Rho family in fibroblasts, which is mediated by one or more members of the heterotrimeric G i family and by PI3K.
Requirement for G i proteins is unrelated to Gli transcriptional activity. We previously reported that G i is necessary for activation of Gli by Shh and by a mutant activated SMO in NIH 3T3 cells (14) . While the activation of Rac1 and RhoA by Shh seem too rapid to be a consequence of a transcriptional event, we wanted to rule out that PTX was inhibiting small GTPase activation by impairing Gli transcriptional activity. In contrast to our findings in NIH 3T3 cells, induction of the Gli-target genes gli1 and ptc1 in Ptc1 +/-MEFs in response to Shh or purmorphamine was not affected at all by treatment with PTX, as determined by RT-PCR or real time PCR (Fig. 7A and B) . As a control, KAAD-cyclopamine completely prevented gli1 and ptc1 induction, and LY294002 had a significant inhibitory effect as well, as previously described by us (26) . The same was observed in primary MEFs (data not shown). Moreover, expression of gli1 in unstimulated Ptc1 -/-MEFs was high, consistent with constitutive SMO activity, and was also insensitive to PTX but sensitive to KAAD-cyclopamine and LY294002 (Fig. 7C) . SMO -/-MEFs were used as a control for basal SMO-dependent gli1 expression (Fig. 7C) .
Since the insensitivity of Gli activation to PTX in MEFs was unexpected, we considered the possibility that they express significant levels of G z . PTX catalyzes the ADP-ribosylation of the Gα subunits of all G i family members with the exception of Gα z . However, Gα z was barely, if at all, detectable in MEFs by western blot of total membrane fractions (Fig. 7D) . The very low levels of G z plus the almost complete sensitivity of events underlying migration to PTX as a control for the efficacy of the toxin attest to the fact that G i function is not required for the activation of Gli in MEFs.
In order to more firmly establish that migration and activation of Rho and Rac by Shh is independent of the canonical (Gli) pathway in MEFs, we inhibited Gli-mediated transcription with a GFP fusion of Gli3R, which competes at the promoter regions for Gli-binding sites and acts as a strong repressor of Gli transcription (28) .
Ptc1
+/-MEFs were infected with Gli3R-GFP AdV or GFP AdV (control), serum-starved overnight, and exposed the following day to vehicle or purmorphamine for 5 min. Rac-pulldown assays showed that neither expression of Gli3R-GFP nor GFP alone impaired Rac activation by purmorphamine (Figs. 8A and B) . In addition, expression of Gli3R did not perturb Shh-induced fibroblast migration (Fig. 8C and D) . These data confirm that the rapid effects of Shh on cell motility through engagement of small GTPases are independent of Gli transcriptional activity.
SMO variants rescue activation of Rac and Rho in SMO-null fibroblasts irrespectively of the canonical Hh pathway. For activation of the canonical, Gli-dependent pathway, SMO undergoes translocation to the primary cilium of cells, a single organelle transiently formed during interphase by both lateral plasma membrane diffusion and by fusion of intracellular SMOcontaining vesicles. Translocation of SMO is promoted by purmorphamine and other SMO synthetic agonists and is prevented by Ptc1. Ciliary localization of SMO requires a two-residue motif at the beginning of the intracellular C-tail. The C-tail is an essential domain for β-arrestin recruitment and interaction with Su(Fu), both prerequisites for Gli activation, but is dispensable for coupling to heterotrimeric G i proteins (14, 29, 30) . To evaluate if migration of fibroblasts and activation of the small GTPases Rac1 and RhoA in response to Shh are independent of the canonical Hh pathway, we introduced different SMO variants into SMO -/-MEFs to evaluate which domain of SMO can rescue the defects in migration and small GTPase activation. We generated stable SMO-null transfectants harboring empty plasmid, SMO-M2 (W535L), which is constitutively active toward both G i and the Gli activation pathway, SMO-M2-CLD (W535L;W549A;R550A), which is reported to be ciliary localization-deficient (31), and SMO-M2-ΔC (SMO 1-551; W535L), which activates G i but is unable to activate Gli (14) . Using an antibody directed toward the C-terminal region of SMO (including the 7th transmembrane domain), we verified expression of SMO-M2 and SMO-M2-CLD in geneticin-resistant cells and a weaker expression of SMO-M2-ΔC (Fig. 9A) . Expression of Gli-target genes was restored in MEFs expressing SMO-M2, as expected, but not in those expressing SMO-M2-ΔC (Fig. 9B) . Unexpectedly, gli1 expression was also restored in MEFs expressing the ciliary localization-deficient SMO variant, in apparent contrast with a recent publication (31) . All three SMO-M2 variants and most remarkably SMO-M2-ΔC, were able to rescue the activation of Rac1 and RhoA irrespectively of their ability to activate the canonical pathway (Fig. 8B and C) . Finally, we found that basal migration rate in wound-healing assays was significantly increased in SMO -/-MEFs stably expressing all three SMO-M2 variants (Fig.  8D) . The results with SMO-M2-ΔC demonstrate again the capacity of SMO to activate events underlying migration in a fashion independent of Gli.
DISCUSSION
The function of SMO as a G proteincoupled receptor, often overlooked in view of what many perceive as a G protein-independent engagement of Gli transcription factors, is central for activation of Rho family GTPases by Shh and, consequently, for Shh-dependent migration of fibroblasts. The present study underscores a duality in transduction, wherein the activation of Rho GTPases and stimulation of migration occur through G i and are independent of the engagement of Gli. The requirement for SMO in the actions of Shh is based on i) the pro-migratory actions of purmorphamine, an agonist working directly on Smo, ii) enhanced migration of Ptc -/-MEFs that is sensitive to KAAD-cyclopamine, and iii) impaired migration in SMO -/-MEFs. The requirement for G i is based on sensitivity of migration to PTX. In this regard, we note that both wildtype and truncated forms of SMO couple strongly and selectively to this family of G proteins (14) . The requirement for signaling apart from Gli is based on the activity of a SMO mutant devoid of the C-tail and the inactivity of a repressor of Gli signaling toward migration.
We extended our previous studies (18) to confirm that not only is RhoA a target for Smo through G i , but that the activation proceeds through Rac1 in a hierarchal fashion and that both of the monomeric G proteins underlie migration. It has been previously documented in Swiss 3T3 fibroblasts that microinjection of a mutant active Rac1V12 stimulates actin polymerization with by guest on January 9, 2018 http://www.jbc.org/ Downloaded from formation of membrane ruffles first, and after 20-30 min induces Rho-dependent formation of stress fibers (32) . Moreover, inhibition of Rac function by expression of dominant negative RacN17 blocks activation of RhoA induced by several growth factors, including PDGF, EGF, and insulin (32, 33) . Our findings that RhoA activation is dependent on Rac1 activity are in line with these observations. Those same growth factors activate Rac and Rho through a mechanism dependent on PI3K activity, as assessed by sensitivity to wortmannin (33) . These growth factors act on tyrosine kinase receptors, ours (Shh and purmorphamine) however act on a 7-TM receptor. In this regard, lysophosphatidic acid (LPA) and bombesin, also acting on 7-TM receptors, activate Rac1 through G i /PI3K (33) and RhoA through G 13 /RhoGEFs (reviewed in 34) in fibroblasts. SMO is unable to couple directly to G 13 (14) , thus the stimulation of RhoA by SMO can be explained only by a hierarchal G i /PI3K/Rac1 series of activations; the activation of RhoA by Rac1 could conceivably be related to transactivation of a G 13 -coupled receptor. Despite the rarity of G i -mediated activation of RhoA in the literature, this is not completely unprecedented since stimulation of muscarinic receptors by carbachol results in Rho activation and stress fiber formation in a pertussis toxin-sensitive manner (35) .
It would seem that Hh signaling diverges at the level of SMO into transcriptional and nontranscriptional, cytoskeletal pathways, akin to signaling achieved by the Frizzled receptors for Wnts. In Wnt signaling, different pairs of ligand/receptor engage either the canonical β-catenin pathway (transcriptional) or the planar polarity (cytoskeletal) pathway in a cell-type specific fashion (36, 37) . Not surprisingly, Frizzled receptors and SMO are sole members of a subfamily among the GPCR superfamily (38) and Frizzled has also been shown to couple to the G i protein family, specifically to G o (39) . This unprecedented parallel perhaps exposes a conservation of functions related by the structure of these atypical GPCRs.
The function and localization of SMO is regulated by specific regions of the protein: a mutant of SMO lacking the C tail retains the ability to couple to G i , indicating that the intracellular loops of SMO mediate interaction with G i , as is the case for most GPCRs (40).
Indeed, this mutant couples more efficiently with G i2 than the full-length protein (14) , suggesting a partial steric inhibition by the C-tail. The form of SMO lacking the C tail is, however, unable to engage the pathway targeting Gli. The C tail, therefore is required for canonical signaling, yet it, too, is insufficient in this regard (14, 30) . Clearly, two or more elements of Smo structure are relevant to the canonical pathway. In the case of NIH 3T3 fibroblasts, zebrafish embryos (41), and the Drosophila wing imaginal disc (42), one of these elements is G i . In some cells, for example MEFs, it is not. We believe the requirement for G i as it pertains to Gli activation can be superceded in some cells by other forms of signaling perhaps unrelated to SMO.
Our results with SMO lacking the C-tail clearly indicate that the C-tail is not required for RhoA and Rac1 activation, as it is not required for heterotrimeric G i proteins. These results suggest that regulation of the cell motility is a prototypical non-canonical response to Shh. We also tested whether a two residue mutation of SMO (W549A; R550A) that purportedly prevents translocation to the primary cilium, and therefore cannot activate Gli, could restore a migratory response to SMOdeficient cells. As expected, the mutation on a constitutively active SMO background (SMO-M2-CLD) rescued the phenotype, but it also induced activation of Gli. We do not know the reason for the discrepancy in our results in relation to those published, but we believe that the active conformation of SMO-M2 can perhaps promote ciliary localization independently of the WR motif, perhaps due to β-arrestin2 binding.
In summary, our findings underscore noncanonical signaling of SMO through G i and monomeric G proteins as an important facet of Hh signaling. Our data are limited to migration, however a number of events documented for Hh signaling occur in a time-frame that all but precludes transcription as a basis. These include not only fibroblast migration but also axon guidance, endothelial tubulogenesis, reduction of caspase activation by growth factor withdrawal (17) (18) (19) . To what extent any of these are under the control of G i remains to be documented. The emerging parallels between SMO and Frizzleds, as well, may help inform the activities under control of the non-canonical pathway. 
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